Home > OHSU Works > Faculty and Staff Work > FDA Drug Approval Documents > Obsessive Compulsive Disorder > Search Results

Obsessive Compulsive Disorder

The reviews of obsessive compulsive disorder drugs provided data for the articles entitled Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders, spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature, Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression, and Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysis.

Search:

Search Tips :: Advanced Search

Sort by

ascending
descending

Display

Collections

Select collection Select collection

Format

Select output format

Fulltext Search

Off Fulltext search toggle

Publication Type

Article (3)

Year

1996 (1)
1994 (2)

Name

United States. Food and Drug Administration (3)

Collection

FDA Drug Approval Documents (3)
Obsessive Compulsive Disorder (3)

Obsessive Compulsive Disorder	3 records found	Search took 0.21 seconds.

1.	Multiple Files fdadrug_34 Sertraline hydrochloride United States. Food and Drug Administration. Application Number: 19-839/S-002 ; Brand name: Zoloft 1996-01-01 \| Article \| Detailed record - Similar records
2.	PDF fdadrug_33 Fluvoxamine maleate United States. Food and Drug Administration. Application Number: 20-243 ; Brand name: Luvox 1994-01-01 \| Article \| Detailed record - Similar records
3.	PDF fdadrug_32 Fluoxetine hydrochloride United States. Food and Drug Administration. Application Number: 20-187 ; Brand name: Prozac 1994-01-01 \| Article \| Detailed record - Similar records

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.